Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[W]hen ethics are abandoned for epics, and when political power subverts rational military decision-making, it is not surprising that symptoms of strategic fatigue begin to develop.